Park Avenue Securities LLC reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.5% during the second quarter, according to the company’s most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,164 shares of the medical research company after selling 56 shares during the quarter. Park Avenue […]